Hinge Health (NYSE:HNGE) Trading Down 6.1% - Should You Sell?

Hinge Health Inc. (NYSE:HNGE - Get Free Report)'s stock price dropped 6.1% during trading on Monday . The stock traded as low as $43.73 and last traded at $43.80. Approximately 78,255 shares traded hands during trading, a decline of 93% from the average daily volume of 1,047,572 shares. The stock had previously closed at $46.63.

Wall Street Analyst Weigh In

HNGE has been the subject of several research reports. Royal Bank Of Canada initiated coverage on shares of Hinge Health in a research note on Monday, June 16th. They set an "outperform" rating and a $45.00 price objective for the company. Evercore ISI initiated coverage on shares of Hinge Health in a research note on Monday, June 16th. They set an "outperform" rating and a $50.00 price objective for the company. Bank of America began coverage on shares of Hinge Health in a research note on Monday, June 16th. They set a "buy" rating and a $42.00 price objective for the company. Truist Financial began coverage on shares of Hinge Health in a research report on Monday, June 16th. They set a "buy" rating and a $48.00 target price for the company. Finally, Stifel Nicolaus began coverage on shares of Hinge Health in a research report on Monday, June 16th. They set a "buy" rating and a $48.00 target price for the company. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $46.00.

Hinge Health Stock Performance

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.